Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

LXEOLXEO
7 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in LEXEO THERAPEUTICS INC

BANK OF AMERICA CORP /DE/ holds 490,331 shares of LXEO (LEXEO THERAPEUTICS INC), worth $2.3M as of 2026-Q2. The position was decreased (-0.2% shares). LXEO represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$2.3M

Current Shares

490,331

Total Value Change

+$2.1M

Total Shares Change

+459,955

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
490,331
-0.2%
$2.3M0.0%$4.66
0
2026-Q1
Increased
491,532
+206.7%
$2.8M0.0%$7.07
42
2025-Q4
Increased
160,288
+466.8%
$1.6M0.0%$9.74
41
2025-Q3
Increased
28,279
+6.1%
$187,7730.0%$6.66
16
2025-Q2
Increased
26,653
+22.4%
$107,1460.0%$4.12
18
2025-Q1
Decreased
21,770
-28.3%
$75,5420.0%$4.10
0
2024-Q4
New
30,376
-
$199,8730.0%$6.54
35

Other major holders of LXEO: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used